- Report
- May 2026
- 189 Pages
Global
From €5164EUR$5,850USD£4,457GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- February 2026
- 250 Pages
Global
From €3963EUR$4,490USD£3,421GBP
- Report
- January 2026
- 110 Pages
Global
From €4193EUR$4,750USD£3,619GBP
- Report
- June 2025
- 400 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- June 2025
- 400 Pages
Global
From €4368EUR$4,949USD£3,771GBP
- Report
- February 2026
- 191 Pages
Global
From €4409EUR$4,995USD£3,806GBP
- Report
- February 2026
- 218 Pages
Global
From €4409EUR$4,995USD£3,806GBP
- Report
- May 2025
- 215 Pages
Global
From €4409EUR$4,995USD£3,806GBP
- Report
- February 2026
- 149 Pages
Global
From €3487EUR$3,950USD£3,009GBP
- Report
- January 2026
- 145 Pages
Global
From €3487EUR$3,950USD£3,009GBP
- Report
- October 2025
- 102 Pages
Global
From €3500EUR$4,248USD£3,127GBP
- Report
- October 2025
- 160 Pages
Global
From €4281EUR$4,850USD£3,695GBP
- Newsletter
- May 2026
Global
€2644EUR$2,995USD£2,282GBP
- Report
- October 2025
- 90 Pages
Global
From €4281EUR$4,850USD£3,695GBP
- Report
- January 2026
- 120 Pages
Middle East
From €4369EUR$4,950USD£3,771GBP

Orthobiologics is a field of biotechnology that focuses on the development of products and treatments to improve musculoskeletal health. It includes the use of biological materials such as stem cells, growth factors, and proteins to repair, regenerate, and replace damaged or diseased tissues. Orthobiologics is used to treat a variety of musculoskeletal conditions, including fractures, tendon and ligament injuries, and degenerative joint diseases. It is also used to improve the healing of bone and soft tissue after surgery.
Orthobiologics is a rapidly growing field, with new products and treatments being developed to improve patient outcomes. It is becoming increasingly important in the treatment of musculoskeletal conditions, as it offers a more natural and less invasive approach than traditional treatments.
Some companies in the Orthobiologics market include Acelity, AlloSource, Arthrex, Bioventus, DePuy Synthes, Exactech, Integra LifeSciences, Medtronic, MiMedx, Orthofix, and Stryker. Show Less Read more